Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro
<p>Abstract</p> <p>Background</p> <p>Drug resistance remains a great challenge in the treatment of gastric cancer. The goal of this study was to explore the anti-tumor effects and mechanism of cytokine-induced killer (CIK) cell combined with oxaliplatin (L-OHP) in human...
Main Authors: | Zhao Qun, Zhang Hui, Li Yong, Liu Jun, Hu Xiaojie, Fan Liqiao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-08-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Online Access: | http://www.jeccr.com/content/29/1/118 |
Similar Items
-
Oxaliplatin-Induced Lhermitte’s Sign in Gastric Cancer
by: Takeshi Okamoto, et al.
Published: (2020-01-01) -
Luteolin Suppresses the Proliferation of Gastric Cancer Cells and Acts in Synergy with Oxaliplatin
by: Li-Qun Ren, et al.
Published: (2020-01-01) -
Predicting effects on oxaliplatin clearance: in vitro, kinetic and clinical studies of calcium- and magnesium-mediated oxaliplatin degradation
by: Catherine H. Han, et al.
Published: (2017-06-01) -
Effect of S-1 combined with oxaliplatin on serum tumor markers, matrix metalloproteinase and immune function in elderly patients with gastric cancer
by: Yong-Feng Shan, et al.
Published: (2017-10-01) -
Comparison on Efficacy of S-1 Respectively Combined with Oxaliplatin and Docetaxel for Advanced Gastric Cancer
by: Junna Zhi, et al.
Published: (2014-03-01)